Skip to main content
. 2024 Jul 8;7(7):e2234. doi: 10.1002/hsr2.2234

Table 3.

Relationship of clinical respiratory illness with ST‐elevation myocardial infarction by study seasons.

Clinical respiratory illness status Total NSTEMI n (%) STEMI n (%) RRa (95% CI) aRRb (95% CI)
All seasons
No 660 93 (14.1) 567 (85.9) Ref. Ref.
Yes 84 12 (14.3) 72 (85.7) 0.99 (0.91–1.09) 1.03 (0.87–1.22)
2017 influenza season
No 36 12 (33.3) 24 (66.7) Ref. Ref.
Yes 20 6 (30.0) 14 (70.0) 1.05 (0.73–1.52) 1.03 (0.60–1.75)
During 2017/2018 non‐influenza season
No 183 38 (20.8) 145 (79.2) Ref. Ref.
Yes 27 3 (11.1) 24 (88.9) 1.12 (0.96–1.31) 1.05 (0.82–1.34)
During 2018 influenza season
No 441 43 (9.8) 398 (90.2) Ref. Ref.
Yes 37 3 (8.1) 34 (91.9) 1.02 (0.92–1.13) 1.01 (0.87–1.19)
During all influenza seasons c
No 477 55 (11.5) 422 (88.5) Ref. Ref.
Yes 57 9 (15.8) 48 (84.2) 0.95 (0.85–1.06) 0.92 (0.29–2.87)

Abbreviations: aRR, adjusted relative risk; BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; NSTEMI, non‐ST‐segment elevation myocardial infarction; RR, relative risk; STEMI, ST‐segment elevation myocardial infarction.

a

RR: unadjusted relative risk.

b

aRR: adjusted relative risk; adjusted for age, sex, tobacco use, hypertension, diabetes, high blood cholesterol, heart failure, exercise level, previous history of CHD, family history of CVD and BMI.

c

Includes both annual influenza seasons of 2017 and 2018.